Government of Alberta   Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2011
NCT01278992
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Government of Alberta

Active Ingredients

Drugs in Phase 3 Trials (1)

hydroxychloroquine (plaquenil) (1 trial)

Drugs in Phase 2 Trials (1)

rhodiola rosea, l (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatigue (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2